Isochroman derivatives and compositions and uses thereof

US2024190835A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024190835-A1
Application numberUS-202218554071-A
CountryUS
Kind codeA1
Filing dateApr 7, 2022
Priority dateApr 8, 2021
Publication dateJun 13, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are isochromane and related compounds, and pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disease and disorders in a subject in need are also disclosed.

First claim

Opening claim text (preview).

1 . A compound of Table 1, wherein said compound is of structure: TABLE 1

Assignees

Inventors

Classifications

  • Benzo[c]pyrans · CPC title

  • Benzo [c] furans; Hydrogenated benzo [c] furans · CPC title

  • condensed with carbocyclic rings, e.g. methantheline  {(cannabinoids A61K31/658)} · CPC title

  • condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone · CPC title

  • C07D313/08Primary

    condensed with one six-membered ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024190835A1 cover?
Disclosed are isochromane and related compounds, and pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disease and disorders in a subject in need are also disclosed.
Who is the assignee on this patent?
Sunovion Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07D313/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).